Episurf Medical AB has signed a distribution agreement for Switzerland with Swiss OrthoGenix GmbH. The agreement covers the distribution of Episurf's personalized knee implant, the Episealer® femoral condyle.

Ahead of the planned international product launch of Episealer® Knee, Episurf Medical has developed a new website in English released today. Episurf Medical has developed a unique approach to personalized knee implants, and the company plans to initiate a controlled European launch during the current quarter. To see this new webpage please visit www.episurf.com

Episurf Medical AB has signed a distribution agreement for Poland with Biocare Therapeutics Sp.zo. It is the company's first European distribution agreement and concerns the distribution of Episurf's personalized knee implant, the Episealer femoral condyle.

The Swedish high-tech company Nanologica receives 5 million SEK from the EU and Vinnova to create the next generation of super materials including those enabling cheaper and more effective drugs. The new materials are expected to be ready for use during the first half of 2014.

On February 4, almost on the anniversary of AstraZeneca closure of the company's research and development activities in Södertälje, SP Process Development opened its doors here on the premises. The goal of the Institute is to strengthen Swedish innovation and build the skills and infrastructure necessary to become a bridge between academia and industry.

The patient from Episurfs first clinical surgery has undergone 6-week control. The patient experiences no pain from the previous cartilage injury and is back at work after four weeks. The rehabilitation is progressing exactly as planned.

Nanologica has signed an agreement with the leading Russian biotech company Nanolek for the formulation of four drugs based on Nanolgica's unique materials platform. The deal represents a commercial breakthrough for Nanologica's new pharmaceutical supermaterials.

From February 3-6 OrganoClick willshowcase and launch its biodegradable and water-repellent fabric technology OrganoTex® at ISPO in Munich, one of the world's largest outdoor fairs. Before the fair a renowned jury based on six different criteria has selected 45 of 2,300 exhibitors whose products are considered to most innovative. OrganoTex® is one such company and will be illustrated additionalyl promoted in the fair's "Textrend Forum".

The first historic surgery on the knee with Episurf's method was done last week by Dr. Nicolas Martinez Carranza in Stockholm, with the desired result. This means that an the individualized implant is surgically inserted into the damaged cartilage area using a guiding instrument. The technology is unique in the world and is predicted to be an effective treatment for early-stage cartilage damage and in stopping the progression of osteoarthritic deterioration.